Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04749446 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study on Clinical Features and Outcomes of Breast Sarcoma

Study acronym: Breast-Sarc
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Dec 1, 2025 to Dec 1, 2026v7
  2. Primary and study completion dates: Dec 1, 2023 to Dec 1, 2025v6
  3. Primary and study completion dates: Jul 1, 2022 to Dec 1, 2023v5
  4. Primary and study completion dates: Jul 1, 2021 to Jul 1, 2022v4
  5. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Mar 31, 2021 to Apr 2, 2021
    • Site details revised at 14 of 14 sites
    v3
  6. Start date: Feb 20, 2021 to Mar 31, 2021v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Italian Sarcoma Group
11 trials monitored
See 1 trial at risk
Sarcoma
1,026 trials monitored
See 67 trials at risk
This is multi-institutional retrospective study in order to identify the most relevant clinical characteristics, treatment strategies, to explore the impact on principal clinical outcomes and finally, to suggest some principles for management and treatment of breast sarcomas. The study will collect data about patients affected by breast sarcoma referred to participating Institutions between January 2000 and June 2020
Trial Details
NCT Number NCT04749446
Lead Sponsor Italian Sarcoma Group
Conditions
(from sponsor)		 Breast Sarcoma
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov